TY - JOUR
T1 - Functional neoglycopeptides
T2 - synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains
AU - Matsushita, Takahiko
AU - Sadamoto, Reiko
AU - Ohyabu, Naoki
AU - Nakata, Hideki
AU - Fumoto, Masataka
AU - Fujitani, Naoki
AU - Takegawa, Yasuhiro
AU - Sakamoto, Takeshi
AU - Kurogochi, Masaki
AU - Hinou, Hiroshi
AU - Shimizu, Hiroki
AU - Ito, Takaomi
AU - Naruchi, Kentarou
AU - Togame, Hiroko
AU - Takemoto, Hiroshi
AU - Kondo, Hirosato
AU - Nishimura, Shin Ichiro
PY - 2009/11/24
Y1 - 2009/11/24
N2 - An efficient protocol for the construction of MUC1-related glycopeptide analogues having complex O-glycan and N-glycan chains was established by integrating chemical and enzymatic approaches on the functional polymer platforms. We demonstrated the feasibility of sortase A-mediated ligation between two glycopeptide segments by tagging with signal peptides, LPKTGLR and GG, at each C- or N-terminal position. Structural analysis of the macromolecular N,O-glycopeptides was performed by means of ESI-TOFMS (MS/MS) equipped with an electron-captured dissociation device. Immunological assay using MUC1 glycopeptides synthesized in this study revealed that N-glycosylation near the antigenic O-glycosylated PDTR motif did not disturb the interaction between the anti-MUC1 monoclonal antibody and this crucial O-glycopeptide moiety.NMR study indicated that the N-terminal immunodominant region [Ala-Pro-Asp-Thr(O-glycan)- Arg] forms an inverse γ-turn-like structure, while the C-terminal region composed of N-glycopeptide and linker SrtA-peptide was proved to be an independently random structure. These results indicate that the bulky O- and N-glycan chains can function independently as disease-relevant epitopes and ligands for carbohydrate-binding proteins, when both are combined by an artificial intervening peptide having a possible effect of separating N- and C-terminal regions. The present strategy will greatly facilitate rapid synthesis of multiply functionalized complex neoglycopeptides as new types of convenient tools or models for the investigation of thhe structure-function relationship of various glycoproteins and development of novel class glycopeptide-based biopharmaceuticals, drug delivery systems, and biomedical materials.
AB - An efficient protocol for the construction of MUC1-related glycopeptide analogues having complex O-glycan and N-glycan chains was established by integrating chemical and enzymatic approaches on the functional polymer platforms. We demonstrated the feasibility of sortase A-mediated ligation between two glycopeptide segments by tagging with signal peptides, LPKTGLR and GG, at each C- or N-terminal position. Structural analysis of the macromolecular N,O-glycopeptides was performed by means of ESI-TOFMS (MS/MS) equipped with an electron-captured dissociation device. Immunological assay using MUC1 glycopeptides synthesized in this study revealed that N-glycosylation near the antigenic O-glycosylated PDTR motif did not disturb the interaction between the anti-MUC1 monoclonal antibody and this crucial O-glycopeptide moiety.NMR study indicated that the N-terminal immunodominant region [Ala-Pro-Asp-Thr(O-glycan)- Arg] forms an inverse γ-turn-like structure, while the C-terminal region composed of N-glycopeptide and linker SrtA-peptide was proved to be an independently random structure. These results indicate that the bulky O- and N-glycan chains can function independently as disease-relevant epitopes and ligands for carbohydrate-binding proteins, when both are combined by an artificial intervening peptide having a possible effect of separating N- and C-terminal regions. The present strategy will greatly facilitate rapid synthesis of multiply functionalized complex neoglycopeptides as new types of convenient tools or models for the investigation of thhe structure-function relationship of various glycoproteins and development of novel class glycopeptide-based biopharmaceuticals, drug delivery systems, and biomedical materials.
UR - http://www.scopus.com/inward/record.url?scp=72749110017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72749110017&partnerID=8YFLogxK
U2 - 10.1021/bi901557a
DO - 10.1021/bi901557a
M3 - Article
C2 - 19852465
AN - SCOPUS:72749110017
SN - 0006-2960
VL - 48
SP - 11117
EP - 11133
JO - Biochemistry
JF - Biochemistry
IS - 46
ER -